Semaglutide Shows Promise in Reversing Osteoarthritis Damage
A new study reveals that semaglutide, commonly used for diabetes and weight loss, may reverse tissue damage caused by osteoarthritis. Researchers found it protects joints in mice and improves function in humans, suggesting a significant breakthrough in treating this widespread condition.
The study indicates semaglutide reprograms cartilage cell metabolism, enhancing energy production independently of weight loss. In trials, participants receiving semaglutide showed reduced pain and improved knee function. Experts urge caution, noting that mouse results may not fully predict human outcomes.
What are your thoughts on this potential treatment?
#HealthNews #Osteoarthritis #Semaglutide
https://www.sciencealert.com/semaglutide-may-reverse-damage-caused-by-osteoarthritis-study-suggests